SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nicholas Rauch who wrote (1020)3/30/1999 11:52:00 AM
From: vestor  Read Replies (1) of 1837
 
DRMD is not really a biotech company. True, that they went the NDA route with Cenestin but that was unusual for them and it will be worth the effort. When the marketing partner is announced and advertising begins there will be investors.... I say again investors flocking to this stock...... The FDA approval was go-ahead to produce a drug that I expect to be well received by a huge audience..... Meanwhile take advantage of the momentum players movement to other momentum plays..... They are giving us an opportunity to buy on the cheap..... Remember the only reason mentioned here that one should sell is because the charts say so and, to some, this is a biotech company and all go back down..... accumulate...... and be patient.... Drop by your local pharmacy and ask them about Cenestin if its like the feedback my wife has been getting it will capture more than 10 % market share.... I make the above statements without the assistence of any charts..... IMHO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News